https://www.selleckchem.com/pr....oducts/gilteritinib-
To investigate if calcitonin gene-related peptide infusion induces migraine-like attacks in chronic migraine patients. Fifty-eight patients with chronic migraine, either with or without headache on the experimental day, were assessed for the incidence of migraine-like attacks after an intravenous infusion with calcitonin gene-related peptide 1.5 µg/min over 20 min. The primary endpoint was the incidence of migraine-like attacks after calcitonin gene-related peptide. Exploratory endpoints were the association between the inc
Like
Comment
Share
